November 27, 2024 Autosomal Recessive Polycystic Kidney Disease (ARPKD)Adjunct EL-PFDD Scientific Workshop Report The mission of the Polycystic Kidney Disease Foundation is to fund research, advocate for patients, and ultimately to end PKD..
December 12, 2024 Investigating item response theory model performance in the context of evaluating clinical outcome assessments in clinical trials Item response theory (IRT) models are an increasingly popular method choice for...
December 10, 2024 Biomarkers 101: A Patient’s Perspective on the Importance of Identifying New Biomarkers Biomarkers are emerging as powerful tools in the field of kidney health, playing a crucial role in the diagnosis, monitoring...
November 27, 2024 A computational tool to optimize clinical trial parameter selection in Duchenne muscular dystrophy: A practical guide and case studies Duchenne muscular dystrophy (DMD), a rare pediatric disease, presents numerous challenges when designing clinical trials...
December 1, 2024 Advancing rare disease measurement through the Rare Disease Clinical Outcome Assessment Consortium Naomi Knoble, and Lindsey T. Murray on behalf of the Rare Disease Clinical Outcome Assessment Consortium. View all authors and aff
November 27, 2024 C-Path’s Romero, Swingle Named to 100 Most Innovative and Influential Healthcare Leaders in AZ Big Media C-Path CEO Klaus Romero and President & COO Kristen Swingle, President and COO were recently named to the 100 Most...
November 19, 2024 C-Path’s TRxA Announces $1 Million Award for Drug Development Project in Type 1 Diabetes C-Path today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership...
November 17, 2024 Advancing Neonatal Drug Development: Celebrating Progress on World Prematurity Day On this occasion of World Prematurity Awareness Day, we reflect on the immense progress we have made together and recognize...
November 14, 2024 Advanced in Vitro Modelling of Neuromuscular Diseases and Therapeutics Join this webinar to explore innovative, multidisciplinary approaches in disease modeling, drug testing, and tissue engineering...
November 14, 2024 C-Path’s Initiative to Optimize Clinical Trial Design in New-Onset Type 1 Diabetes In honor of World Diabetes Day and the need to improve diabetes treatment, Critical Path Institute’s Type 1 Diabetes Consortium